NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE151000 Query DataSets for GSE151000
Status Public on May 01, 2021
Title Lineage transcription factors ASCL1, NKX2-1, and PROX1 are enriched at super enhancers and co-regulate subtype-specific genes in small cell lung cancer [RNA-seq]
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Heterogeneity between tumors is a major barrier to the treatment of small cell lung cancer (SCLC). Identification of molecular markers to characterize and classify tumors can facilitate the diagnosis and development of targeted therapies. Here, we analyzed genomic regions, called super enhancers (SE), across multiple SCLC cell lines and patient-derived xenograft models, and find SE enrichment is sufficient to classify SCLC models into recently defined SCLC molecular subtypes SCLC-A, SCLC-N, and SCLC-P defined by the transcription factors ASCL1, NEUROD1, and POU2F3, respectively. 3D chromatin structure analysis identified genes associated with the SE that assemble into subtype-specific tumor-signatures with genes functioning in diverse processes. Focusing on the SCLC-A subtype, transcription factors NKX2-1 and PROX1 were identified as ASCL1-interacting proteins. All three factors bind overlapping genomic regions within SEs in SCLC-A cell line models. Nevertheless, combined loss of all three factors suppresses growth of SCLC-A similar to that seen with ASCL1 loss alone, continuing to place ASCL1 as a key dependency factor in a subset of SCLC. Focusing on genes co-regulated by the three transcription factors, two SCLC-A subtype-specific cell surface proteins, SCN3A and KCNB2, were identified. Loss of either channel alone did not disrupt SCLC-A growth in vitro, but they may serve as diagnostic tools in subtyping SCLC.
 
Overall design Identification of transcriptional targets that are shared between ASCL1, PROK1 and NKX2.1 (TTF1) in the NCI-H2107 SCLC cell line, by knocking down ASCL1 or ASCL/PROX1/NKX2.1 with siRNAs and RNA-seq.
 
Contributor(s) Pozo K, Kollipara RK, Johnson JE
Citation(s) 34466783, 36325065
Submission date May 21, 2020
Last update date Nov 28, 2023
Contact name Jane E Johnson
E-mail(s) [email protected]
Organization name UT Southwestern Medical Center
Department Neuroscience
Street address 5323 Harry Hines Blvd
City Dallas
State/province TX
ZIP/Postal code 75390-9111
Country USA
 
Platforms (1)
GPL21697 NextSeq 550 (Homo sapiens)
Samples (10)
GSM4563941 H2107 3TF KD rep1
GSM4563942 H2107 3TF KD rep2
GSM4563943 H2107 ASCL1 KD rep1
This SubSeries is part of SuperSeries:
GSE151002 Lineage transcription factors ASCL1, NKX2-1, and PROX1 are enriched at super enhancers and co-regulate subtype-specific genes in small cell lung cancer
Relations
BioProject PRJNA634352
SRA SRP262644

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE151000_H2107_ASCL1_ANP_KD_fpkm_whole_genome.txt.gz 497.6 Kb (ftp)(http) TXT
GSE151000_hSCLC_PDX_fpkm_whole_genome.txt.gz 382.8 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap